Clinical Trials List
2025-09-01 - 2030-06-30
Recruiting7
ICD-10C7A.1
Malignant poorly differentiated neuroendocrine tumors
ICD-10C7A.8
Other malignant neuroendocrine tumors
ICD-10C7B.09
Secondary carcinoid tumors of other sites
ICD-10C7B.1
Secondary Merkel cell carcinoma
ICD-10C7B.8
Other secondary neuroendocrine tumors
ICD-10C80.0
Disseminated malignant neoplasm, unspecified
ICD-10D3A.8
Other benign neuroendocrine tumors
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9199.0
Disseminated malignant neoplasm
-
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Cheng-Lun Lai Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- 謝合原 Division of Hematology & Oncology
- YI-CHUN LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯萬盛 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳佳哲 Division of Hematology & Oncology
- 林偉哲 Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 李易濰 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 林昶廷 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 蔡宗翰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡承志 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林泰祺 Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- 周昱百 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳尚俊 Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
49 participants
-
Global
492 participants
